Durata Therapeutics Information
Summary
Durata Therapeutics is a public company that has been in the industry for 17 years. The company currently specializes in the Pharmaceuticals area. The position of the CEO is occupied by Paul Edick. Its headquarters is located at Chicago, Illinois, USA. The number of employees ranges from 25 to 100. The annual revenue of Durata Therapeutics varies between 5.0M and 25M. Total funding of the company - $67.5M. To connect with Durata Therapeutics employee register on SignalHire.
Organization Website | duratatherapeutics.com |
Industries | |
Headquarters Location | 200 South Wacker Drive, Chicago, IL, 60606 US |
Employees Size | 100-200 employees |
Specialties | Infectious Diseases, Acute Illnesses |
DMA Code | Chicago Metropolitan Area |
Founded | 01/2009 |
Estimated Annual Revenue | $5.0M - 25M |
Operating Status | Out Of Business |
Employees Turnover 4 quarter 2025
Length of Employment
Employee tenure at Durata Therapeutics shows a diverse range of experience levels:
100% have over 11 years of service at Durata Therapeutics
Similar Companies
FAQ
Data Privacy
GDPR COMPLIANT
SignalHire complies with the General Data Protection Regulation (GDPR). SignalHire follows GDPR requirements, including but not limited to rights of data subjects to access, correct, or delete their personal information and supports the right to be forgotten.
CCPA COMPLIANT
SignalHire is CCPA-compliant and provides California residents the right to know, access, opt out, and request deletion of their personal data.
